Genmab vs Hemab Therapeutics
Genmab
Differentiated human antibody therapeutics for the treatment of cancer
3102 employees · est. 1999 · Denmark
Hemab Therapeutics
The next generation of therapeutics for bleeding and thrombotic disorders
114 employees · est. 2020 · Frederiksberg, Denmark
Genmab is the older company (1999 vs 2020); Genmab is the larger of the two.
Side-by-Side Comparison
| Metric | Genmab | Hemab Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 1999 older | 2020 |
| Headquarters | ||
| Headquarters | Denmark | Frederiksberg, Denmark |
| Employees | ||
| Employees | 3102 larger | 114 |
| Industry | ||
| Industry | Biotechnology, Pharmaceutical | Biotechnology, Life Sciences, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Series B |
| Total Funding | ||
| Total Funding | $2.28B | $190.00M |
| Funding Rounds | ||
| Funding Rounds | 6 | 3 |
| Services | ||
| Services | Development of Antibody Therapeutics, Pipeline of Medicines, Biotech Research | Developing therapies for bleeding disorders, Conducting clinical trials, Research in blood coagulation disorders, Providing educational resources |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients & Care Partners, Investors, Corporate Partners | Patients with bleeding disorders, Caregivers, Healthcare providers, Investors, Medical researchers |
| Taxonomy | ||
| Taxonomy | Antibody TherapeuticsCancer TreatmentBispecific AntibodiesAntibody-Drug ConjugatesImmune-Modulating AntibodiesClinical Pipeline +7 | TherapeuticsBleeding DisordersThrombotic DisordersMonoclonal AntibodiesBispecific AntibodiesProphylactic Treatments +8 |
| Website | ||
| Website | genmab.com | hemab.com |
About Genmab
Genmab, founded in 1999, is a pioneering international biotechnology company headquartered in Denmark. Renowned for its expertise in antibody innovation, Genmab focuses on developing differentiated human antibody therapeutics aimed at treating cancer and other serious diseases. Through its innovativ...
About Hemab Therapeutics
Hemab Therapeutics, founded in 2020, is a clinical-stage biotech company specializing in the development of prophylactic therapeutics for bleeding and thrombotic disorders. With headquarters in both Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is dedicated to transforming the treatment la...
Also comparing in this category
Comparing more than these two?
Get Genmab, Hemab Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Genmab compare?
A PDF of Genmab and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Genmab with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Genmab on 25 Jun 2026, and Hemab Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
